Funded Tech Companies
YmAbs Therapeutics
YmAbs Therapeutics is a biopharmaceutical tech venture, located in New York. Financial backing came from Scopia Capital Management, Sofinnova Ventures and HBM Healthcare Investments.
Company Overview
Company Name
YmAbs Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
230 Park Ave. 3350
New York, NY 10169
USA
New York, NY 10169
USA
Phone
Website
Email Address
Company Background Information
Overview
YmAbs Therapeutics is a clinical stage biopharmaceutical company focused on developing new cancer treatments through immunotherapies. Our lead antibody programs target GD2 and B7-H3. In addition, YmAbs utilizes its platform technologies to create next-generation humanized, affinity matured bispecific antibodies.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/30/2017
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Claus Moller
Chief Financial Officer
Bo Kruse
Chief Medical Officer
Steen Lisby
Chief Operating Officer
Joris Wilms
President
Thomas Gad
VP - Operations
Torben Lund-Hansen
Company Investors
- Scopia Capital Management
- Sofinnova Ventures
- HBM Healthcare Investments (Andreas Wicki)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs